New G7 support gives COVAX program a shot in the arm

COVAX, the push to equitably distribute COVID-19 vaccine throughout the world, got a major boost with a fresh infusion of pledges, as G7 leaders gathered virtually at a security conference. In other international developments, Johnson & Johnson submitted its COVID-19 vaccine for World Health Organization (WHO) assessment, and two researchers published more promising findings for already listed vaccines, AstraZeneca-Oxford and Pfizer-BioNTech.